CHICAGO–(BUSINESS WIRE)–Monroe Capital LLC today announced an increase in the credit facility to Luxury Optical Holdings (“LOH”) to support continued growth of the business. LOH is a portfolio company of aPriori Capital Partners and Goode Partners. Based in Las Vegas, Nevada, Luxury Optical Holdings is the leading retailer of luxury eyewear with specialty boutiques in key markets across the United States. LOH’s key retail concepts include Robert Marc, Optica, Scene, Morgenthal Frederics, Dava
CARLSBAD, Calif.–(BUSINESS WIRE)–GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, announced today that Hany Massarany, President and Chief Executive Officer, will present at th…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Phase 2 Results Published in Eye and Contact Lens Demonstrate Statistically Significant and Clinically Meaningful Improvements with EBI-005 and Support Planned Phase 3 Clinical Study Design
PALM BEACH GARDENS, Fla.–(BUSINESS WIRE)–Tyrogenex, privately held company focused on the development of next-generation targeted therapeutics for cancer and ophthalmology, announced the initiation of a phase 2 study referred to as “APEX.”
IRVINE, Calif. & BEDMINSTER, N.J. & RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) (the “Company”), announced today that its first quarter 2015 financial results will be released after the market closes on Thursday, May 7, 2015. Following the release, the Company will host a live conference call and webcast at 5:00 p.m. Eastern Time to discuss the Company’s financial results and provide a general business and strategic update. Additionally, the Company
DALLAS–(BUSINESS WIRE)–Vital Art and Science, LLC (VAS), an emerging ophthalmic medical device company, has introduced the mVT™ Service, an innovative medical device and physician portal that conveniently and accurately tracks the progression of vision damaging diseases such as age related macular degeneration and diabetic retinopathy. The device is available only by prescription and consists of an easily downloaded app that can be used on any Apple smartphone or tablet. Patient test data are
BOSTON–(BUSINESS WIRE)–Stealth BioTherapeutics (Stealth), a clinical-stage biopharmaceutical company developing drug candidates for mitochondrial dysfunction, today announced expansion of its ophthalmology program.
COLUMBUS, Ohio–(BUSINESS WIRE)–The Cataract & Refractive Center of Ohio released an advisory alert to educate people across the Midwest about a new treatment for chronic eye problems suffered by millions of Americans. Those problems are often worse during the spring in the Midwest, when the air is flooded with pollen from maple trees and other plants. In the advisory, Alice T. Epitropoulos, MD, FACS, co-founder of The Eye Center of Columbus, explains that more than 23 million Americans su
TOKYO–(BUSINESS WIRE)–R-Tech Ueno (JASDAQ:4573) This is to announce that R-Tech Ueno, Ltd. (Head Office: Chiyoda-ku, Tokyo, CEO and President: Yukihiko Mashima, hereinafter referred to as “R-Tech Ueno”) has acquired the right to develop and commercia…
SEATTLE–(BUSINESS WIRE)–Acucela Inc. (TOKYO:4589), a clinical-stage biotechnology company that specializes in discovering and developing novel drug candidates to potentially treat and slow the progression of sight-threatening ophthalmic diseases, tod…
IRVINE, Calif. & BEDMINSTER, N.J. & RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye, today reported the results of its first Phase 3 registration trial (Rocket 1) for RhopressaTM, a novel once-daily, triple-action eye drop being tested for its ability to
TARRYTOWN, N.Y.–(BUSINESS WIRE)–Prestige Brands Holdings, Inc. (NYSE:PBH) announced today that Matthew M. Mannelly, President and Chief Executive Officer and member of the Board of Directors, will retire effective June 1, 2015. Following his retirement, the Board of Directors has appointed Ron Lombardi, Chief Financial Officer, to succeed Mr. Mannelly as President and Chief Executive Officer. The company has commenced a search for a new Chief Financial Officer. “Ron and Matt have worked toget
ALPHARETTA, Ga.–(BUSINESS WIRE)–Clearside Biomedical, which develops drug therapies to treat eye diseases, announces acquisition of iScience Interventional Corp.’s patent portfolio covering drug delivery to the suprachoroidal space.
DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/kjmvvr/global_and) has announced the addition of the “Global and Chinese Visual chart monitor Industry, 2010-2020 Market Research Report” report to their offering…
MURRIETA, Calif.–(BUSINESS WIRE)–II-VI Optical Systems (II-VI OS) will present at the SPIE-DSS show in Baltimore Maryland, April 20-23, 2015, Booth #725.
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Eleven Biotherapeutics to Report First Quarter 2015 Financial Results on April 30, 2015
DUBLIN–(BUSINESS WIRE)–Presbia Announces the Start of Commercialization of the Presbia Flexivue Micolens™ in Australia
INDIANAPOLIS–(BUSINESS WIRE)–Anthem, Inc., offers six tips for maintaining healthy eyes in recognition of Women’s Eye Health and Safety Month.
LONDON–(BUSINESS WIRE)–Technavio has published a new report on the smart glasses market for augmented reality (AR), which is expected to grow at a CAGR 194.2% from 2015-2019.
SUNNYVALE, Calif.–(BUSINESS WIRE)–Phase 3 trial data showed that IBI-10090 is highly effective in treating inflammation post cataract surgery.